Large gap with delayed quotes
|
Last quote
12/27/2024 -
20:00:00
|
Bid
12/27/2024 -
15:59:59
|
Bid Volume |
Ask
12/27/2024 -
15:59:59
|
Ask Volume |
|---|---|---|---|---|
|
80.24
-0.33
(
-0.41% )
|
80.22
|
700 |
80.27
|
4,000 |
Analysis date: 24.12.2024
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 12.11.2024.
Interest
Weak
Weak
Weak interest since 06.12.2024.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 06.12.2024 at a price of 77.72.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, at its current price the stock is moderately overvalued.
MT Tech Trend
Positive
Positive
The forty day Medium Term Technical Trend is positive since 12.11.2024. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 74.548.
4wk Rel Perf
2.22%
2.22%
The four week relative overperformance versus SP500 is 2.22%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 02.08.2024.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.01%.
Mkt Cap in $bn
31.07
31.07
With a market capitalization >$8bn, DEXCOM is considered a large-cap stock.
G/PE Ratio
0.78
0.78
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
33.44
33.44
The estimated PE is for the year 2026.
LT Growth
26.02%
26.02%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
20
20
Over the last seven weeks, an average of 20 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
82
82
For 1% of index variation, the stock varies on average by 0.82%.
Correlation
0.20
0.20
Stock movements are totally independent of index variations.
Value at Risk
19.26
19.26
The value at risk is estimated at USD 19.26. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
06.04.2011
06.04.2011